Atomoxetine suppresses radioresistance in glioblastoma via circATIC/miR-520d-5p/Notch2-Hey1 axis
Hyun Jeong Seok, Jae Yeon Choi, Dong Hyeon Lee, Incheol Shin, In Hwa Bae · 2024
Read Atomoxetine suppresses radioresistance in glioblastoma via circATIC/miR-520d-5p/Notch2-Hey1 axis by Hyun Jeong Seok, Jae Yeon Choi, Dong Hyeon Lee, Incheol Shin, In Hwa Bae (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11536942.txt.
Description
Hyun Jeong Seok and four co-authors show that atomoxetine, a known drug, can curb ray-proof growth in a grave brain tumor. Their study appeared in twenty twenty-four. Brain tumors that bear rays and grow back are a top cause of cure fail. Stem-like traits and shape shift in tumor cells tie to that proof state, so drugs that cut those traits are sought.
The team screened a shelf of cleared drugs on proof tumor cells and picked atomoxetine. It curbed move, spread, and ball growth in lab tests and shrank grafts in mice. Probes traced the act to a loop of RNA marks that drive two key genes. Blood from patients backed the marks, which the team flags as cure and test aims.
Catalog record
| CREATOR | Hyun Jeong Seok, Jae Yeon Choi, Dong Hyeon Lee, Incheol Shin, In Hwa Bae |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |